Sanofi completed a significant financing event on November 3, 2025, issuing $3.0 Billion in new senior unsecured and unsubordinated notes across five tranches, governed by an Indenture (NY Law) with Deutsche Bank Trust Company Americas as Trustee. The issuance was underwritten by a syndicate including Barclays and BofA Securities, supporting the company’s Form F-3 registration.
The debt issuance diversifies maturity profiles:
Floating Rate Notes (Total $1.0 Billion):
- $500M due 2027: Interest based on Compounded SOFR + 46bps (0% floor), resetting quarterly. Priced at 99.800% of pa